VolitionRX Ltd (VNRX) - Product Pipeline Analysis, 2018 Update

Products Id :- GDME321317PD
|
Pages: 69
|
August 2018
|
Region: Asia
|

Request for Sample Report

Request A Quote

Executive Summary

Summary

VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of various conditions including colorectal cancer, prostate and lung cancers, and inflammatory and other diseases. VolitionRX also conducts research and development, and offers clinical trial services. The company has collaboration with hospital, medical center, universities and research institute. It operates in Belgium, Singapore, the UK and the US. VolitionRX is headquartered in Singapore City, Singapore.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company VolitionRX Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

VolitionRX Ltd Company Overview 6

VolitionRX Ltd Company Snapshot 6

VolitionRX Ltd Pipeline Products and Ongoing Clinical Trials Overview 6

VolitionRX Ltd-Pipeline Analysis Overview 8

VolitionRX Ltd-Key Facts 8

VolitionRX Ltd-Major Products and Services 9

VolitionRX Ltd Pipeline Products by Development Stage 10

VolitionRX Ltd Ongoing Clinical Trials by Trial Status 14

VolitionRX Ltd Pipeline Products Overview 16

HyperGenomics Diagnostic Test-Colon Cancer 16

HyperGenomics Diagnostic Test-Colon Cancer Product Overview 16

HyperGenomics Diagnostic Test-Leukaemia 17

HyperGenomics Diagnostic Test-Leukaemia Product Overview 17

HyperGenomics Diagnostic Test-Prostate Cancer 18

HyperGenomics Diagnostic Test-Prostate Cancer Product Overview 18

Nu.Q CRC Screening Test 19

Nu.Q CRC Screening Test Product Overview 19

Nu.Q CRC Screening Test Clinical Trial 20

Nu.Q CRC Symptomatic Test 21

Nu.Q CRC Symptomatic Test Product Overview 21

Nu.Q CRC Triage Test 22

Nu.Q CRC Triage Test Product Overview 22

Nu.Q Frontline Asymptomatic CRC Screening Test 23

Nu.Q Frontline Asymptomatic CRC Screening Test Product Overview 23

Nu.Q Frontline Asymptomatic CRC Screening Test Clinical Trial 24

NuQ-A Androgen Receptor Cell Culture ELISA Kit 25

NuQ-A Androgen Receptor Cell Culture ELISA Kit Product Overview 25

NuQ-A EZH2 Cell Culture ELISA Kit 26

NuQ-A EZH2 Cell Culture ELISA Kit Product Overview 26

NuQ-A HMGB1 Cell Culture ELISA Kit 27

NuQ-A HMGB1 Cell Culture ELISA Kit Product Overview 27

NuQ-A Oestrogen Receptor Cell Culture ELISA Kit 28

NuQ-A Oestrogen Receptor Cell Culture ELISA Kit Product Overview 28

NuQ-A Progesterone Receptor Cell Culture ELISA Kit 29

NuQ-A Progesterone Receptor Cell Culture ELISA Kit Product Overview 29

NuQ-Prostate Cancer 30

NuQ-Prostate Cancer Product Overview 30

NuQ-Prostate Cancer Clinical Trial 31

NuQ-T001 Total Nucleosome ELISA Kit 32

NuQ-T001 Total Nucleosome ELISA Kit Product Overview 32

NuQ Diagnostic Test-Lung Cancer 33

NuQ Diagnostic Test-Lung Cancer Product Overview 33

NuQ Diagnostic Test-Lung Cancer Clinical Trial 34

NuQ Diagnostic Test-Pancreatic Cancer 35

NuQ Diagnostic Test-Pancreatic Cancer Product Overview 35

NuQ Diagnostic Test-Pancreatic Cancer Clinical Trial 36

NuQ Endo 37

NuQ Endo Product Overview 37

NuQ Endo Clinical Trial 38

NuQ T003 Assay-Colorectal Cancer 39

NuQ T003 Assay-Colorectal Cancer Product Overview 39

NuQ V001 Assay-Colorectal Cancer 40

NuQ V001 Assay-Colorectal Cancer Product Overview 40

NuQ X001S Assay-Colorectal Cancer 41

NuQ X001S Assay-Colorectal Cancer Product Overview 41

NuQ X001S Assay-Colorectal Cancer Clinical Trial 42

NuQ-B 43

NuQ-B Product Overview 43

NuQ-IHC 44

NuQ-IHC Product Overview 44

NuQ-M Gamma-H2AX Cell Culture ELISA Kit 45

NuQ-M Gamma-H2AX Cell Culture ELISA Kit Product Overview 45

NuQ-M H3K27(Me)3 Cell Culture ELISA Kit 46

NuQ-M H3K27(Me)3 Cell Culture ELISA Kit Product Overview 46

NuQ-M H4K16(Ac) Cell Culture ELISA Kit 47

NuQ-M H4K16(Ac) Cell Culture ELISA Kit Product Overview 47

NuQ-M H4K20(Me)3 Cell Culture ELISA Kit 48

NuQ-M H4K20(Me)3 Cell Culture ELISA Kit Product Overview 48

NuQ-M H4Pan(Ac) Cell Culture ELISA Kit 49

NuQ-M H4Pan(Ac) Cell Culture ELISA Kit Product Overview 49

NuQ-M Ubiquityl H2A Cell Culture ELISA Kit 50

NuQ-M Ubiquityl H2A Cell Culture ELISA Kit Product Overview 50

NuQ-V 51

NuQ-V Product Overview 51

NuQ-V mH2A1.1 Cell Culture ELISA Kit 52

NuQ-V mH2A1.1 Cell Culture ELISA Kit Product Overview 52

NuQ-V mH2A2 Cell Culture ELISA Kit 53

NuQ-V mH2A2 Cell Culture ELISA Kit Product Overview 53

NuQ-X Hydroxymethylated DNA Cell Culture Kit 54

NuQ-X Hydroxymethylated DNA Cell Culture Kit Product Overview 54

NuQ-X Methylated DNA Cell Culture Kit 55

NuQ-X Methylated DNA Cell Culture Kit Product Overview 55

VolitionRX Ltd-Key Competitors 56

VolitionRX Ltd-Key Employees 57

VolitionRX Ltd-Locations And Subsidiaries 58

Head Office 58

Other Locations & Subsidiaries 58

Recent Developments 59

VolitionRX Ltd, Recent Developments 59

Jul 10, 2018: Volition expands clinical development of Nu.Q to Asia Pacific 59

May 10, 2018: VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update 59

May 09, 2018: VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits 60

Mar 07, 2018: VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board 60

Mar 01, 2018: VolitionRX Announces Full Fiscal Year 2017 Financial Results and Business Update 61

Feb 26, 2018: VolitionRx Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer 62

Feb 05, 2018: VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark 63

Jan 03, 2018: VolitionRx Releases Letter to Shareholders Including Status Update on Key Clinical Milestone 63

Nov 09, 2017: VolitionRx Announces Third Quarter 2017 Financial Results and Business Update 64

Sep 22, 2017: VolitionRx Announces the Initial Sale of its New Nu.Q Research Kits 65

Appendix 66

Methodology 66

About GlobalData 69

Disclaimer 69

List of Figures

VolitionRX Ltd Pipeline Products by Equipment Type 7

VolitionRX Ltd Pipeline Products by Development Stage 10

VolitionRX Ltd Ongoing Clinical Trials by Trial Status 14

List of Tables

VolitionRX Ltd Pipeline Products and Ongoing Clinical Trials Overview 6

VolitionRX Ltd Pipeline Products by Equipment Type 7

VolitionRX Ltd Pipeline Products by Indication 7

VolitionRX Ltd Ongoing Clinical Trials by Trial Status 7

VolitionRX Ltd, Key Facts 8

VolitionRX Ltd, Major Products and Services 9

VolitionRX Ltd Number of Pipeline Products by Development Stage 10

VolitionRX Ltd Pipeline Products Summary by Development Stage 11

VolitionRX Ltd Ongoing Clinical Trials by Trial Status 14

VolitionRX Ltd Ongoing Clinical Trials Summary 15

HyperGenomics Diagnostic Test-Colon Cancer-Product Status 16

HyperGenomics Diagnostic Test-Colon Cancer-Product Description 16

HyperGenomics Diagnostic Test-Leukaemia-Product Status 17

HyperGenomics Diagnostic Test-Leukaemia-Product Description 17

HyperGenomics Diagnostic Test-Prostate Cancer-Product Status 18

HyperGenomics Diagnostic Test-Prostate Cancer-Product Description 18

Nu.Q CRC Screening Test-Product Status 19

Nu.Q CRC Screening Test-Product Description 19

Nu.Q CRC Screening Test-A Large Multi-center US Clinical Study of Nu.Q Assay in the Screening of Colorectal Cancer 20

Nu.Q CRC Screening Test-Prospective Clinical Study Nu.Q Assay for the Detection of Colorectal Cancer 20

Nu.Q CRC Symptomatic Test-Product Status 21

Nu.Q CRC Symptomatic Test-Product Description 21

Nu.Q CRC Triage Test-Product Status 22

Nu.Q CRC Triage Test-Product Description 22

Nu.Q Frontline Asymptomatic CRC Screening Test-Product Status 23

Nu.Q Frontline Asymptomatic CRC Screening Test-Product Description 23

Nu.Q Frontline Asymptomatic CRC Screening Test-Asymptomatic Colorectal Cancer (CRC) Frontline Screening Study 24

NuQ-A Androgen Receptor Cell Culture ELISA Kit-Product Status 25

NuQ-A Androgen Receptor Cell Culture ELISA Kit-Product Description 25

NuQ-A EZH2 Cell Culture ELISA Kit-Product Status 26

NuQ-A EZH2 Cell Culture ELISA Kit-Product Description 26

NuQ-A HMGB1 Cell Culture ELISA Kit-Product Status 27

NuQ-A HMGB1 Cell Culture ELISA Kit-Product Description 27

NuQ-A Oestrogen Receptor Cell Culture ELISA Kit-Product Status 28

NuQ-A Oestrogen Receptor Cell Culture ELISA Kit-Product Description 28

NuQ-A Progesterone Receptor Cell Culture ELISA Kit-Product Status 29

NuQ-A Progesterone Receptor Cell Culture ELISA Kit-Product Description 29

NuQ-Prostate Cancer-Product Status 30

NuQ-Prostate Cancer-Product Description 30

NuQ-Prostate Cancer-A Retrospective Study to Establish the Efficacy of VolitionRx's NuQ Test to Distinguish Anaplastic Prostate Cancer 31

NuQ-Prostate Cancer-Evaluate the Accuracy of Nu.Q Assay in Diagnosis of Aggressive Prostate Cancer 31

NuQ-Prostate Cancer-Multicenter study to evaluate ability of NuQ to detect prostate cancer 31

NuQ-T001 Total Nucleosome ELISA Kit-Product Status 32

NuQ-T001 Total Nucleosome ELISA Kit-Product Description 32

NuQ Diagnostic Test-Lung Cancer-Product Status 33

NuQ Diagnostic Test-Lung Cancer-Product Description 33

NuQ Diagnostic Test-Lung Cancer-Detection of Lung Cancer with NuQ Blood Test 34

NuQ Diagnostic Test-Lung Cancer-Study to evaluate NuQ for early detection of 27 most prevalent cancers; and to evaluate differences in nucleosome structures between cancers 34

NuQ Diagnostic Test-Pancreatic Cancer-Product Status 35

NuQ Diagnostic Test-Pancreatic Cancer-Product Description 35

NuQ Diagnostic Test-Pancreatic Cancer-Clinical Trial with German Cancer Research Center (DKFZ) to Evaluate NuQ Blood Test for Pancreatic Cancer 36

NuQ Endo-Product Status 37

NuQ Endo-Product Description 37

NuQ Endo-Study to Evaluate the Efficacy of Nu.Q Platform Technology in Diagnosis of Endometriosis 38

NuQ T003 Assay-Colorectal Cancer-Product Status 39

NuQ T003 Assay-Colorectal Cancer-Product Description 39

NuQ V001 Assay-Colorectal Cancer-Product Status 40

NuQ V001 Assay-Colorectal Cancer-Product Description 40

NuQ X001S Assay-Colorectal Cancer-Product Status 41

NuQ X001S Assay-Colorectal Cancer-Product Description 41

NuQ X001S Assay-Colorectal Cancer-Evaluate the Accuracy of NuQ Assays as an Initial Screening Tool for Detecting Colorectal Cancer: A Retrospective Study 42

NuQ-B-Product Status 43

NuQ-B-Product Description 43

NuQ-IHC-Product Status 44

NuQ-IHC-Product Description 44

NuQ-M Gamma-H2AX Cell Culture ELISA Kit-Product Status 45

NuQ-M Gamma-H2AX Cell Culture ELISA Kit-Product Description 45

NuQ-M H3K27(Me)3 Cell Culture ELISA Kit-Product Status 46

NuQ-M H3K27(Me)3 Cell Culture ELISA Kit-Product Description 46

NuQ-M H4K16(Ac) Cell Culture ELISA Kit-Product Status 47

NuQ-M H4K16(Ac) Cell Culture ELISA Kit-Product Description 47

NuQ-M H4K20(Me)3 Cell Culture ELISA Kit-Product Status 48

NuQ-M H4K20(Me)3 Cell Culture ELISA Kit-Product Description 48

NuQ-M H4Pan(Ac) Cell Culture ELISA Kit-Product Status 49

NuQ-M H4Pan(Ac) Cell Culture ELISA Kit-Product Description 49

NuQ-M Ubiquityl H2A Cell Culture ELISA Kit-Product Status 50

NuQ-M Ubiquityl H2A Cell Culture ELISA Kit-Product Description 50

NuQ-V-Product Status 51

NuQ-V-Product Description 51

NuQ-V mH2A1.1 Cell Culture ELISA Kit-Product Status 52

NuQ-V mH2A1.1 Cell Culture ELISA Kit-Product Description 52

NuQ-V mH2A2 Cell Culture ELISA Kit-Product Status 53

NuQ-V mH2A2 Cell Culture ELISA Kit-Product Description 53

NuQ-X Hydroxymethylated DNA Cell Culture Kit-Product Status 54

NuQ-X Hydroxymethylated DNA Cell Culture Kit-Product Description 54

NuQ-X Methylated DNA Cell Culture Kit-Product Status 55

NuQ-X Methylated DNA Cell Culture Kit-Product Description 55

VolitionRX Ltd, Key Employees 57

VolitionRX Ltd, Subsidiaries 58

Glossary 68

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

SciGen Ltd

PathGEN Dx Pte. Ltd.

Kino Biotech Co Ltd

Epigenomics AG

Abbott Laboratories

Ab Sciex Pte Ltd

VolitionRX Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

VolitionRX Ltd (VNRX) - Product Pipeline Analysis, 2018 Update

The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara"

Wish to Know more

download

For Further Enquiry

apply for job

Know how We Roll

Engage with Us